Fermish is a reputed regulatory consulting organization known for its high quality services in life science industries. Fermish was established by Dr. Khalid khan in 2005. The company primarily assist the pharmaceutical industries in various aspects of regulatory compliance activities to facilitate meeting the regulatory standards across the globe and to get market acceptance.

Fermish works proactively and diligently in solving complex regulatory challenges which a life science industry may face during registration or marketing authorization of their product. Overall, we help the life science industries to develop and manufacture their product in compliance with regulatory standards within a given timeline.

Apart from regulatory services, we also have an entrusted team of medical/regulatory writers for development of quality documents ranging from journal articles, presentations to complex regulatory dossiers.

We also provide trained staff for regulatory processing as well as scientific project managers to the organizations for assisting regulatory and medical affairs related external as well as internal projects.

Our work methodology aids in easy and timely regulatory compliance of pharmaceutical industry. We foster the growth of regulatory profession and regulatory practitioners with the delivery of most apt regulatory solutions. We empower our clients with expert regulatory solutions which helps them to comply with current regulatory standards and to face any future challenges.

Completed his PhD in Pharmacology from Jamia Hamdard in the year 2008 and since then has been actively involved as a regulatory expert providing consultancy to Indian as well as International organizations. He has solely build up this organizations with his hardwork, honesty and expertise keeping client’s satisfaction at the top priority and is a reputed name in the market.

He has a huge experience of more than 29 in entire spectrum of Clinical Research, Pharmacovigilance and Regulatory Affairs and a thorough regulatory understanding of various pharmaceutical products viz medical devices, rDNA based biotech products, orphan drugs, vaccines and blood derivative products. He also has a vast experience in regulatory writing and submission and has managed diversified therapeutic portfolio: Endocrinology, Oncology, Respiratory, Dermatology, Anti-allergies, Vaccines, Infant Nutrition, Consumer Health.